Diseases (Mar 2022)

Progression of Chronic Kidney Disease and All-Cause Mortality in Patients with Tricuspid Regurgitation

  • Fabian Schipmann,
  • Marwin Bannehr,
  • Valentin Hähnel,
  • Victoria Dworok,
  • Jonathan Nübel,
  • Christoph Edlinger,
  • Michael Lichtenauer,
  • Michael Haase,
  • Michael Zänker,
  • Christian Butter,
  • Anja Haase-Fielitz

DOI
https://doi.org/10.3390/diseases10010016
Journal volume & issue
Vol. 10, no. 1
p. 16

Abstract

Read online

Aim: The impact of chronic kidney disease (CKD) on patient-related outcomes in patients with tricuspid regurgitation (TR) is well known. However, the impact of the progression of CKD in patients with TR and potentially modifiable risk factors of progressing CKD is unknown. Methods: 444 consecutive adult patients with TR and CKD stage 1–4 admitted in an inpatient setting between January 2010 and December 2017 were included. During a median follow-up of two years, eGFR and survival status were collected. Independent risk factors for CKD progression and all-cause mortality were determined. Patient survival statuses were grouped according to different combinations of the presence or absence of CKD progression and the TR grade. Results: Progression of CKD (OR 2.38 (95% confidence interval 1.30–4.35), p = 0.005), the grade of TR (OR 2.38 (1.41–4.00), p = 0.001) and mitral regurgitation (OR 1.72 (1.20–2.46), p = 0.003) were independent risk factors for all-cause mortality. Haemoglobin at admission (OR 0.80 (0.65–0.99), p = 0.043) and the presence of type 2 diabetes (OR 1.67 (1.02–2.73), p = 0.042) were independent risk factors for CKD progression. The combination of the status of CKD progression and the TR grade showed a stepwise pattern for all-cause mortality (p p = 0.002). Conclusion: CKD progression appears to be a risk factor for all-cause mortality in patients with TR. Anaemia and diabetes are potential modifiers of CKD progression.

Keywords